Palisade Bio (FRA:7NS0) Total Assets : €11.64 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Palisade Bio Total Assets?

Palisade Bio's Total Assets for the quarter that ended in Mar. 2024 was €11.64 Mil.

During the past 12 months, Palisade Bio's average Total Assets Growth Rate was -30.00% per year. During the past 3 years, the average Total Assets Growth Rate was -11.10% per year.

During the past 4 years, Palisade Bio's highest 3-Year average Total Assets Growth Rate was -11.10%. The lowest was -11.10%. And the median was -11.10%.

Total Assets is connected with ROA %. Palisade Bio's annualized ROA % for the quarter that ended in Mar. 2024 was -105.85%. Total Assets is also linked to Revenue through Asset Turnover. Palisade Bio's Asset Turnover for the quarter that ended in Mar. 2024 was 0.00.

Palisade Bio Total Assets Historical Data

The historical data trend for Palisade Bio's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palisade Bio Total Assets Chart

Palisade Bio Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Assets

2.48

11.07

14.88

12.89

Palisade Bio Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial											14.26	16.88	15.99	12.89	11.64

Palisade Bio Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Palisade Bio's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	10.374	+	2.512
	=	12.89

Palisade Bio's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	9.259	+	2.381
	=	11.64

Palisade Bio (FRA:7NS0) Total Assets Explanation

Total Assets is connected with ROA %.

Palisade Bio's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-12.98	/	( (12.886	+	11.64)	/ 2 )
	=	-12.98	/	12.263
	=	-105.85 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Palisade Bio's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	0	/	( (12.886	+	11.64)	/ 2 )
=	0	/	12.263
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Palisade Bio Total Assets Related Terms

Thank you for viewing the detailed overview of Palisade Bio's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Palisade Bio (FRA:7NS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palisade Bio Inc (FRA:7NS0) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

PALI:USA

Address

5800 Armada Drive, Suite 2A, Carlsbad, CA, USA, 92008

Website

https://www.palisadebio.com

Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.

Palisade Bio (FRA:7NS0) Headlines

No Headlines